José Eduardo Tanus-Santos Selected Research

José Eduardo Tanus-Santos Research Topics

Disease

10	Hypertension (High Blood Pressure) 06/2023 - 08/2006
4	Vascular Remodeling 01/2023 - 10/2016
2	Obesity 06/2023 - 04/2012
2	Hypoxia (Hypoxemia) 01/2019 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2011 - 05/2010
1	Pediatric Obesity 06/2023
1	Insulin Resistance 06/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2023
1	Hypertrophy 01/2023
1	Mental Disorders (Mental Disorder) 12/2022
1	Prehypertension 10/2021
1	Periodontitis 08/2021
1	Periodontal Diseases (Periodontal Disease) 08/2021
1	Hypertensive Crisis 12/2020
1	Panic Disorder (Panic Attack) 01/2019
1	Renovascular Hypertension (Goldblatt Syndrome) 01/2018
1	Pre-Eclampsia (Preeclampsia) 01/2017
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2017
1	Overweight 09/2016
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2016
1	Atherosclerosis 04/2014
1	Inflammation (Inflammations) 04/2014
1	Erectile Dysfunction 11/2013
1	Endometriosis 05/2013
1	Disease Resistance 08/2012
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2012
1	Multiple Sclerosis 09/2009
1	Vascular Diseases (Vascular Disease) 06/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2008
1	Acute Lung Injury 06/2008
1	Cardiomyopathies (Cardiomyopathy) 08/2006
1	Pulmonary Embolism 01/2004

Drug/Important Bio-Agent (IBA)

5	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021 - 05/2010
4	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 05/2013
2	Protein Isoforms (Isoforms)IBA 06/2023 - 06/2008
2	QuercetinIBA 01/2023 - 01/2018
2	FlavonoidsIBA 01/2023 - 01/2018
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2021 - 07/2012
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2020 - 09/2009
2	EnzymesIBA 01/2017 - 04/2012
2	CholesterolIBA 09/2016 - 04/2014
1	AdiponectinIBA 06/2023
1	Biomarkers (Surrogate Marker)IBA 06/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022
1	vascular factorIBA 12/2022
1	pimagedine (aminoguanidine)IBA 01/2019
1	2-amino-7-phosphonoheptanoic acidIBA 01/2019
1	2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA 01/2019
1	NitritesIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 10/2016
1	salicylhydroxamic acid (SHAM)IBA 10/2016
1	Messenger RNA (mRNA)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2016
1	Triglycerides (Triacylglycerol)IBA 09/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2016
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 02/2016
1	CytokinesIBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2014
1	HDL LipoproteinsIBA 04/2014
1	Ethanol (Ethyl Alcohol)IBA 11/2013
1	Proteins (Proteins, Gene)FDA Link 11/2013
1	AnionsIBA 06/2013
1	Uric Acid (Urate)IBA 06/2013
1	Superoxides (Superoxide)IBA 06/2013
1	Metalloproteases (Metalloproteinases)IBA 05/2013
1	MercuryIBA 05/2010
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 06/2008
1	Arginine (L-Arginine)FDA Link 06/2008
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 08/2006
1	Sildenafil Citrate (Viagra)FDA Link 08/2006

Therapy/Procedure

3	Therapeutics 01/2017 - 01/2004
1	Ligation 08/2021
1	Injections 01/2019
1	Drug Therapy (Chemotherapy) 08/2012